Covaxin maker Bharat Biotech’s nasal vaccine ready to take on new covid strains
Bharat Biotech is ready to adapt its intranasal and injectable covid vaccines for new variants as India reports 5,755 active cases and four new deaths. Health officials have identified two new JN.1 variants, prompting increased testing and medical preparedness across the country.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
